Company | Price d* | Change d* | Volume, Avg. k, d* | Market Cap. d* | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding d* | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biotechnology Average | - - | - - | - - | 13,981.41 | 865.39 | 213.75 | -166.90 | 35.82 | 0.03 | 14.4430 | -0.40 | -115.2825 | -2,534.7213 | -9.88 | -11.09 | 785.3614 | - - | ||
Maximum | - - | - - | - - | 593,737.00 | 65,349.00 | 25,407.00 | 99,050.00 | 5,305.00 | 0.94 | 1,336.3467 | 6.70 | 300.5100 | 8,534.8500 | 14.64 | 835.37 | 6,156.2100 | - - | ||
Minimum | - - | - - | - - | 0.00 | 0.00 | -1,175.00 | -56,335.00 | -1,185.00 | 0.00 | -164.8536 | -8.99 | -10,177.5800 | -144,478.0000 | -155.91 | -1,263.79 | 0.0700 | - - | ||
TG Therapeutics, Inc. TGTX | 25.28 | 0.03 0.12% | 3,815 vs. 3,227 | 3,913.00 | 63.00 | -10.00 | -8.00 | -1,525.00 | -0.0732 | -50.4229 | 0.00 | 91.30 | -16.87 | -6.69 | -2.87 | 275.64 | 154.00 | ||
Madrigal Pharmaceuticals, Inc. MDGL | 242.25 | 9.09 3.90% | 287 vs. 281 | 5,259.00 | 0.00 | -147.00 | -149.00 | -1,483.00 | -7.3800 | -8.6674 | 0.00 | 0.00 | 0.00 | -17.34 | -13.63 | 926.23 | 21.00 | ||
Exelixis, Inc. EXEL | 26.83 | 0.01 0.04% | 2,426 vs. 1,764 | 7,653.00 | 425.00 | 37.00 | 50.00 | -258.00 | 0.1200 | 47.8131 | 0.00 | 95.00 | 8.78 | 1.75 | 1.33 | 322.73 | 285.00 | ||
Akero Therapeutics, Inc. AKRO | 28.00 | 1.04 3.86% | 462 vs. 646 | 1,944.00 | 0.00 | -53.00 | -35.00 | -627.00 | -0.9000 | -6.6902 | 0.00 | 0.00 | 0.00 | -6.30 | -5.85 | 2986.43 | 69.00 | ||
Reata Pharmaceuticals, Inc. RETA | 172.36 | 0.04 0.02% | 1,909 vs. 954 | 6,566.00 | 22.00 | 192.00 | -70.00 | -1,490.00 | 5.1200 | 5.4820 | 0.00 | 96.28 | 848.49 | 221.10 | 38.40 | 282.09 | 38.00 |